Literature DB >> 31271741

Analytical and clinical performance of three hand-held point-of-care creatinine analyzers for renal function measurements prior to contrast-enhanced imaging.

Catharina van der Heijden1, Laurence Roosens1, Hugo Cluckers1, Amaryllis H Van Craenenbroeck2, Bart Peeters3.   

Abstract

BACKGROUND: As iodine-based contrast can cause deterioration of renal function in patients with impaired kidney function, guidelines advise to measure creatinine and calculate estimated glomerular filtration (eGFR) prior to administration. Point-of-care (POC) devices seem an attractive alternative to central laboratory testing but uncertainty regarding analytical and clinical comparability remains.
METHODS: This study compared three POC devices, i-STAT (Abbott), StatSensor (Nova) and epoc (Siemens) with a central laboratory method (enzymatic creatinine, Siemens Vista 1500 platform). 120 patients were included and underwent simultaneous finger prick capillary blood analysis on the StatSensor and heparine whole blood analysis on StatSensor, i-STAT and epoc.
RESULTS: All POC devices generated results which showed considerable variability around the creatinine value of the reference standard, with StatSensor having the widest (-1,12-1,11 mg/dL) and epoc the tightest (-0,49-0,49 mg/dL) 95% limits of agreement. I-STAT showed the highest clinical concordance with the reference standard (Kappa: 0,94) and had the smallest average analytical error (6%) for creatinine and eGFR compared to the reference standard, meeting the predefined criteria of 8,87% and 10%, respectively. Epoc only met criteria for eGFR. StatSensor did not meet any of the criteria.
CONCLUSIONS: I-STAT and epoc were, analytically and clinically, the most performant POC devices included in this study but showed to be less user-friendly. StatSensor did not meet any of the error criteria, neither for creatinine nor for eGFR measurements, and gave more clinical major classification errors. However, it proved to be more user-friendly compared to the other POC devices.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Contrast-enhanced imaging; Contrast-induced kidney injury; Creatinine; Estimated glomerular filtration rate; Point-of-care testing

Mesh:

Substances:

Year:  2019        PMID: 31271741     DOI: 10.1016/j.cca.2019.06.025

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Is point of care renal function testing reliable screening pre-IV contrast administration?

Authors:  Namit Mathur; Zhong X Lu; Lisa MacKay; Theodore Lau; Ahilan Kuganesan; Kenneth K Lau
Journal:  Emerg Radiol       Date:  2020-07-29

2.  Evaluation of the impact of delayed centrifugation on the diagnostic performance of serum creatinine as a baseline measure of renal function before antiretroviral treatment.

Authors:  Chemedzai E Chikomba; Carolyn J Padoa; Donald Tanyanyiwa
Journal:  South Afr J HIV Med       Date:  2020-07-16       Impact factor: 2.744

3.  Pilot study determining the feasibility of implementing the Disadvantaged Populations eGFR Epidemiology Study (DEGREE) protocol, point-of-care field measurements and a new module on risk factors for chronic kidney disease of unknown origin in Hispanic outdoor workers.

Authors:  Erika Figueroa-Solis; David Gimeno Ruiz de Porras; George L Delclos
Journal:  BMC Nephrol       Date:  2021-03-12       Impact factor: 2.388

4.  Performance evaluation of all analytes on the epoc® Blood Analysis System for use in hospital surgical and intensive care units.

Authors:  Zahraa Mohammed-Ali; Sousan Bagherpoor; Pauline Diker; Thuy Hoang; Ivana Vidovic; Christine Cursio; Felix Leung; Davor Brinc
Journal:  Pract Lab Med       Date:  2020-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.